PR Newswire | May 25, 2021 08:01AM EDT

2021

05/25 07:00 CDT

Evofem Biosciences to Present at LD Micro Invitational XI on Tuesday, June 8, 2021 SAN DIEGO, May 25, 2021

SAN DIEGO, May 25, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that its CEO Saundra Pelletier will present at the 2021 LD Micro Invitational XI on Tuesday, June 8, 2021 at 1:00 p.m. ET (10:00 a.m. PT).

Pelletier will provide an update on the commercialization of Evofem's hormone-free contraceptive Phexxi(r) (lactic acid, citric acid and potassium bitartrate), the ongoing Phase 3 clinical trial evaluating EVO100 for the prevention of chlamydia and gonorrhea in women, and other ongoing initiatives.

To pre-register for the presentation, please visit https://ldmicrojune2021.mysequire.com/.

About Evofem BiosciencesEvofem Biosciences, Inc., (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). For more information, please visit evofem.com.

Phexxi(r) is a registered trademark of Evofem Biosciences, Inc.

Investor Relations ContactAmy RaskopfEvofem Biosciences, Inc.araskopf@evofem.comMobile: (917) 673-5775

View original content to download multimedia: http://www.prnewswire.com/news-releases/evofem-biosciences-to-present-at-ld-micro-invitational-xi-on-tuesday-june-8-2021-301298297.html

SOURCE Evofem Biosciences, Inc.